ADAPY · Adaptimmune Therapeutics PLC · Documents
$0.03
+0.00 (+11.30%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2025
Substantial doubt about the company's ability to continue as a going concern.
“the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the financial statements are issued.”View the 10-Q filed Aug 13, 2025
Market Cap
$44.53M
Shares
1.59B
Volume · Oct 20
80.26K
Avg daily vol (3M)
144.54K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-05-06 | — | |
| DEF 14A | — | 2021-04-08 | 2021-05-14 | |
| 8-K | — | 2021-02-25 | — | |
| 10-K | — | 2021-02-25 | 2020-12-31 | |
| 8-K | — | 2020-12-16 | — | |
| 8-K | — | 2020-11-20 | — | |
| 8-K | — | 2020-11-19 | — | |
| 8-K | — | 2020-11-09 | — | |
| 8-K | — | 2020-11-05 | — | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-10-15 | — | |
| 8-K | — | 2020-08-28 | — | |
| 8-K | — | 2020-08-06 | — | |
| 10-Q | — | 2020-08-06 | 2020-06-30 | |
| 8-K | — | 2020-06-02 | 2020-06-01 | |
| 8-K | — | 2020-05-29 | — | |
| 8-K | — | 2020-05-29 | — | |
| 10-Q/A | — | 2020-05-28 | 2020-03-31 | |
| 8-K | — | 2020-05-14 | — | |
| 10-Q | — | 2020-05-14 | 2020-03-31 | |
| 8-K | — | 2020-05-12 | — | |
| 8-K | — | 2020-04-29 | — | |
| 8-K | — | 2020-04-28 | — | |
| DEF 14A | — | 2020-04-20 | 2020-05-29 | |
| 8-K | — | 2020-04-08 | 2020-04-07 | |
| 8-K | — | 2020-02-27 | — | |
| 10-K | — | 2020-02-27 | 2019-12-31 | |
| 8-K | — | 2020-02-18 | 2020-02-17 | |
| 8-K | — | 2020-02-07 | — | |
| 8-K | — | 2020-01-22 | 2020-01-21 | |
| 8-K | — | 2020-01-14 | 2020-01-13 | |
| 8-K | — | 2020-01-13 | — | |
| 8-K | — | 2020-01-13 | — |
Showing 101–133 of 133 filings